Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inflammasomes | 14 | 2024 | 40 | 3.320 |
Why?
|
| Autophagy | 9 | 2025 | 30 | 3.160 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 14 | 2024 | 40 | 3.010 |
Why?
|
| Endothelial Cells | 11 | 2024 | 47 | 2.470 |
Why?
|
| Myocytes, Smooth Muscle | 5 | 2025 | 18 | 2.370 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 3 | 2025 | 11 | 2.100 |
Why?
|
| Muscle, Smooth, Vascular | 7 | 2025 | 23 | 1.870 |
Why?
|
| Sphingomyelin Phosphodiesterase | 5 | 2025 | 13 | 1.800 |
Why?
|
| Animals | 29 | 2025 | 1711 | 1.800 |
Why?
|
| Lysosomes | 7 | 2025 | 21 | 1.600 |
Why?
|
| Atherosclerosis | 3 | 2025 | 16 | 1.600 |
Why?
|
| Mice | 20 | 2025 | 685 | 1.500 |
Why?
|
| Mice, Inbred C57BL | 14 | 2024 | 184 | 1.430 |
Why?
|
| Tight Junctions | 5 | 2024 | 9 | 1.350 |
Why?
|
| Cathepsin B | 4 | 2019 | 7 | 1.300 |
Why?
|
| Cells, Cultured | 13 | 2025 | 127 | 1.260 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 3 | 2024 | 9 | 1.260 |
Why?
|
| Diet, High-Fat | 6 | 2024 | 34 | 1.250 |
Why?
|
| Cell Movement | 5 | 2025 | 61 | 1.210 |
Why?
|
| Acid Ceramidase | 3 | 2024 | 6 | 1.090 |
Why?
|
| Cell Proliferation | 4 | 2025 | 115 | 1.080 |
Why?
|
| HMGB1 Protein | 6 | 2020 | 15 | 1.060 |
Why?
|
| Mice, Knockout | 9 | 2025 | 140 | 1.040 |
Why?
|
| Signal Transduction | 8 | 2025 | 216 | 1.040 |
Why?
|
| Cell Differentiation | 2 | 2025 | 71 | 1.000 |
Why?
|
| Liver | 4 | 2024 | 49 | 0.980 |
Why?
|
| Endothelium, Vascular | 4 | 2021 | 17 | 0.950 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2024 | 6 | 0.890 |
Why?
|
| Liver Cirrhosis | 1 | 2024 | 7 | 0.890 |
Why?
|
| Vascular Calcification | 1 | 2024 | 6 | 0.890 |
Why?
|
| Lipid Metabolism | 1 | 2024 | 13 | 0.880 |
Why?
|
| Homeostasis | 1 | 2024 | 29 | 0.880 |
Why?
|
| Piperidines | 2 | 2025 | 15 | 0.830 |
Why?
|
| Male | 13 | 2024 | 2491 | 0.740 |
Why?
|
| Neointima | 3 | 2023 | 8 | 0.710 |
Why?
|
| Coronary Vessels | 6 | 2024 | 27 | 0.680 |
Why?
|
| Hyperglycemia | 2 | 2019 | 10 | 0.650 |
Why?
|
| Adipokines | 2 | 2019 | 5 | 0.610 |
Why?
|
| Nicotine | 1 | 2019 | 38 | 0.590 |
Why?
|
| Sequestosome-1 Protein | 1 | 2018 | 4 | 0.580 |
Why?
|
| Amitriptyline | 1 | 2018 | 3 | 0.580 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2018 | 4 | 0.580 |
Why?
|
| Neovascularization, Physiologic | 1 | 2018 | 17 | 0.580 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2019 | 9 | 0.540 |
Why?
|
| Intercellular Junctions | 2 | 2019 | 4 | 0.510 |
Why?
|
| Humans | 10 | 2025 | 4936 | 0.480 |
Why?
|
| Dyneins | 1 | 2016 | 2 | 0.480 |
Why?
|
| Phagosomes | 1 | 2016 | 2 | 0.480 |
Why?
|
| Hypercholesterolemia | 2 | 2024 | 13 | 0.410 |
Why?
|
| Macrophages | 3 | 2025 | 26 | 0.400 |
Why?
|
| Reactive Oxygen Species | 4 | 2024 | 30 | 0.380 |
Why?
|
| Extracellular Vesicles | 2 | 2023 | 8 | 0.370 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 225 | 0.360 |
Why?
|
| Capillary Permeability | 2 | 2021 | 3 | 0.310 |
Why?
|
| Cell Line | 4 | 2019 | 84 | 0.310 |
Why?
|
| Interleukin-1beta | 4 | 2024 | 17 | 0.300 |
Why?
|
| Hepatocytes | 2 | 2024 | 13 | 0.270 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 2 | 2019 | 5 | 0.260 |
Why?
|
| Zonula Occludens-1 Protein | 2 | 2024 | 7 | 0.260 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 73 | 0.260 |
Why?
|
| Permeability | 2 | 2016 | 14 | 0.250 |
Why?
|
| Calcineurin | 1 | 2025 | 11 | 0.230 |
Why?
|
| Osteogenesis | 1 | 2024 | 3 | 0.220 |
Why?
|
| Coronary Circulation | 1 | 2024 | 6 | 0.220 |
Why?
|
| Microcirculation | 1 | 2024 | 7 | 0.220 |
Why?
|
| Cell Membrane Permeability | 2 | 2019 | 11 | 0.190 |
Why?
|
| Cell Survival | 2 | 2020 | 54 | 0.190 |
Why?
|
| Caspase 1 | 2 | 2024 | 11 | 0.180 |
Why?
|
| MicroRNAs | 1 | 2021 | 53 | 0.170 |
Why?
|
| Cathepsin D | 1 | 2020 | 1 | 0.170 |
Why?
|
| Mycobacterium bovis | 1 | 2020 | 2 | 0.170 |
Why?
|
| Tuberculosis | 1 | 2020 | 4 | 0.170 |
Why?
|
| Gene Deletion | 2 | 2019 | 15 | 0.170 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 35 | 0.160 |
Why?
|
| Biological Assay | 2 | 2021 | 32 | 0.160 |
Why?
|
| Simvastatin | 1 | 2020 | 5 | 0.160 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2019 | 11 | 0.160 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 9 | 0.150 |
Why?
|
| Aortic Diseases | 1 | 2019 | 4 | 0.150 |
Why?
|
| Endothelium | 1 | 2019 | 4 | 0.150 |
Why?
|
| Carrier Proteins | 2 | 2018 | 23 | 0.150 |
Why?
|
| Aorta | 1 | 2019 | 8 | 0.150 |
Why?
|
| Methylamines | 1 | 2019 | 4 | 0.150 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 18 | 0.150 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2019 | 7 | 0.150 |
Why?
|
| Cell Cycle Proteins | 1 | 2019 | 19 | 0.150 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2019 | 11 | 0.150 |
Why?
|
| RNA Interference | 2 | 2018 | 23 | 0.150 |
Why?
|
| Hyperlipidemias | 1 | 2019 | 9 | 0.150 |
Why?
|
| Lipids | 1 | 2019 | 20 | 0.150 |
Why?
|
| Microscopy, Confocal | 2 | 2018 | 49 | 0.150 |
Why?
|
| Cell Dedifferentiation | 1 | 2018 | 1 | 0.150 |
Why?
|
| Growth Differentiation Factors | 1 | 2018 | 1 | 0.150 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2018 | 2 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2018 | 4 | 0.150 |
Why?
|
| Myofibroblasts | 1 | 2018 | 6 | 0.150 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 4 | 0.150 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 6 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 14 | 0.150 |
Why?
|
| Phosphoproteins | 1 | 2018 | 16 | 0.150 |
Why?
|
| Fibroblasts | 1 | 2018 | 12 | 0.140 |
Why?
|
| Angiotensin II | 1 | 2018 | 13 | 0.140 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 12 | 0.140 |
Why?
|
| Phenotype | 1 | 2018 | 67 | 0.140 |
Why?
|
| Podocytes | 1 | 2019 | 30 | 0.140 |
Why?
|
| Palmitates | 1 | 2016 | 2 | 0.130 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2016 | 3 | 0.130 |
Why?
|
| Streptozocin | 1 | 2016 | 6 | 0.130 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 23 | 0.130 |
Why?
|
| Myocardium | 1 | 2016 | 34 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 24 | 0.120 |
Why?
|
| Tight Junction Proteins | 1 | 2015 | 4 | 0.120 |
Why?
|
| Immunoblotting | 1 | 2015 | 8 | 0.120 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2015 | 4 | 0.120 |
Why?
|
| Ceramides | 2 | 2023 | 4 | 0.100 |
Why?
|
| Up-Regulation | 2 | 2020 | 28 | 0.080 |
Why?
|
| Rickettsia conorii | 1 | 2024 | 6 | 0.060 |
Why?
|
| Ezetimibe | 1 | 2024 | 3 | 0.060 |
Why?
|
| Anticholesteremic Agents | 1 | 2024 | 6 | 0.060 |
Why?
|
| Hyperplasia | 1 | 2023 | 4 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2023 | 10 | 0.050 |
Why?
|
| NLR Proteins | 1 | 2022 | 2 | 0.050 |
Why?
|
| Pyrin Domain | 1 | 2022 | 2 | 0.050 |
Why?
|
| Caspases | 1 | 2022 | 2 | 0.050 |
Why?
|
| Superoxides | 1 | 2022 | 5 | 0.050 |
Why?
|
| Cell Extracts | 1 | 2021 | 2 | 0.050 |
Why?
|
| Microvessels | 1 | 2021 | 6 | 0.040 |
Why?
|
| Autophagosomes | 1 | 2021 | 3 | 0.040 |
Why?
|
| Autophagy-Related Proteins | 1 | 2021 | 4 | 0.040 |
Why?
|
| Endocytosis | 1 | 2020 | 4 | 0.040 |
Why?
|
| NADPH Oxidases | 1 | 2020 | 4 | 0.040 |
Why?
|
| Biomarkers | 1 | 2021 | 81 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2020 | 6 | 0.040 |
Why?
|
| Cadherins | 1 | 2020 | 11 | 0.040 |
Why?
|
| Exosomes | 1 | 2019 | 5 | 0.040 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2019 | 2 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2019 | 2 | 0.040 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 7 | 0.040 |
Why?
|
| Extracellular Space | 1 | 2019 | 2 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 21 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2019 | 12 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2019 | 15 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2019 | 48 | 0.040 |
Why?
|
| Models, Biological | 1 | 2020 | 124 | 0.040 |
Why?
|
| Hydroxamic Acids | 1 | 2018 | 1 | 0.040 |
Why?
|
| Ketocholesterols | 1 | 2018 | 1 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2018 | 4 | 0.040 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2018 | 4 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2019 | 16 | 0.040 |
Why?
|
| Chalcones | 1 | 2018 | 2 | 0.040 |
Why?
|
| Losartan | 1 | 2018 | 3 | 0.040 |
Why?
|
| Phagocytosis | 1 | 2018 | 5 | 0.040 |
Why?
|
| Periodontal Ligament | 1 | 2018 | 1 | 0.040 |
Why?
|
| Thioredoxins | 1 | 2018 | 1 | 0.040 |
Why?
|
| Porphyromonas gingivalis | 1 | 2018 | 1 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2018 | 11 | 0.040 |
Why?
|
| Inflammation | 1 | 2019 | 57 | 0.040 |
Why?
|
| Gene Expression | 1 | 2018 | 49 | 0.030 |
Why?
|
| Hypertension | 1 | 2018 | 58 | 0.030 |
Why?
|
| Obesity | 1 | 2019 | 115 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2018 | 111 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2016 | 13 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2016 | 39 | 0.030 |
Why?
|
| Calcium | 1 | 2016 | 31 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 161 | 0.030 |
Why?
|
| Female | 1 | 2019 | 2523 | 0.020 |
Why?
|